UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002014 |
|---|---|
| Receipt number | R000002455 |
| Scientific Title | Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma |
| Date of disclosure of the study information | 2009/06/19 |
| Last modified on | 2016/03/31 09:18:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/05/29 10:10:58 | ||
| 2 | Update | 2009/06/06 14:00:48 | Key exclusion criteria |
|
| 3 | Update | 2009/06/19 15:01:17 | ||
| 4 | Update | 2009/06/22 12:05:39 | ||
| 5 | Update | 2009/09/15 09:13:11 | Recruitment status |
|
| 6 | Update | 2010/01/13 09:14:06 | Key exclusion criteria Key exclusion criteria |
|
| 7 | Update | 2012/06/01 09:32:36 | Last follow-up date |
|
| 8 | Update | 2012/11/29 09:15:26 | Recruitment status |
|
| 9 | Update | 2013/11/29 09:08:52 | Email Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 10 | Update | 2013/12/06 09:08:44 | Last follow-up date |
|
| 11 | Update | 2014/09/16 18:41:45 | Recruitment status |
|
| 12 | Update | 2014/10/17 13:23:43 | Recruitment status |
|
| 13 | Update | 2015/03/11 09:29:10 | Publication of results |
|
| 14 | Update | 2016/03/31 09:18:48 | URL related to results and publications |
